Deoxyribonucleic Acid Trip
By Gina Maranto,
New York Times
| 08. 28. 2002
Book review of Gregory Stock,
Redesigning Humans: Our Inevitable
Genetic Future.
GREGORY STOCK has written an enthusiastic book in support of
germ-line manipulations -- that is, making genetic modifications
to eggs, sperm and embryos that can be passed on to future generations.
Like previous explorations of the subject by the ethicist Joseph
F. Fletcher, the lawyer John Robertson and the biologist James
Watson, among others, ''Redesigning Humans: Our Inevitable Genetic
Future'' serves as an apologia for those scientists and physicians
who are already edging toward such work in a piecemeal fashion
in research labs and in vitro fertilization clinics around the
world. It advocates the wholesale adoption of genetic manipulations
with the purpose of finally taking control of human evolution.
This, the author writes, ''is the ultimate expression and realization
of our humanity.''
Because of the breadth of his scientific knowledge and his
considerable flair as a writer, Stock -- who heads the program
on medicine, technology and society at the School of Medicine
of the University of California, Los Angeles -- is a forceful
advocate. First and foremost...
Related Articles
What We Inherit by Sam Trejo and Daphne O. Martschenko; and Original Sin by Kathryn Paige Harden have a great deal in common, with substantial differences in style and emphasis. Both books attempt, in different ways, to show the reader just where current research into human genomics stands, where that might be going, and why the authors are interested. In short, the influence of genomic research on our societies is already large and seems likely to change them in ways...
By Dan Falk, Nautilus | 08.20.2026
The pseudoscience of eugenics, founded on the mistaken notion that nature envisions some “right” combination of genes, and that selective breeding can improve the human race, is making a comeback. While the heyday of eugenics was a century ago, the...
By Emily Packard Dawson and Lainie Friedman Ross, MedPage Today | 08.18.2026
Few things evoke a greater sense of desperation than a parent seeking an experimental treatment for their child. That desperation can make even extraordinary risks seem worth taking. This dynamic has come into stark relief after Mei, a 6-year-old girl...
By Ryan Cross, Endpoints News | 08.20.2026
China’s cheap, fast and quiet system for testing cutting-edge medicines is facing scrutiny after the deaths of three people in investigator-initiated trials.
The studies, also known as IITs, allow experimental cell and gene therapies to be tested without oversight from...
